€1.7m · Pre-Seed · Healthtech · Copenhagen, Denmark
Aisel Health, a Copenhagen-based company building software for psychiatric clinics, has raised €1.7m in a pre-seed round led by Caesar Ventures. Nordic Web Ventures, LifeX and Angel Invest also joined, alongside existing investors Rockstart and EIFO. The company says the capital will expand its clinical and engineering teams and support entry into the UK private-psychiatry market.
From faster notes to usable patient context
Aisel is tackling a problem that becomes more visible as clinics adopt AI transcription: producing notes faster does not make a long patient history easier to navigate. The company says its system turns interview recordings, existing documents and patients' own accounts into structured context that clinicians can retrieve before, during and after a consultation.
The product spans more than transcription. Aisel presents adaptive intake, referral summaries, live consultation capture, draft clinical notes and progress tracking as parts of one workflow. Its product examples keep clinicians in the approval loop: generated notes remain drafts, findings cite their source, and unclear or contradictory information is flagged for review rather than silently resolved.
That workflow breadth is the commercial bet. A clinic buying only a scribe gets help with one task after a consultation. A system that also prepares the visit, retrieves prior evidence and structures follow-up can become part of the operating process across the patient journey. If Aisel can fit those steps into existing clinic systems and governance, the product has more ways to save staff time and support additional clinical capacity; if integration creates new work, the promised efficiency weakens.
UK expansion will test workflow fit
Aisel told Danish outlet 24Victoria that it was working with a handful of clinics in Denmark and onboarding its first enterprise customer when the round was announced. The same report said the company had an active UK private-psychiatry pipeline. The funding therefore moves Aisel from product development towards proving that its workflow can travel between clinics and health systems.
The company has also published an observational study of 202 documentation tasks across eight clinics in Denmark and the UK. It reports that clinical-note time fell from 14.5 to 5.5 minutes with Aisel, while noting that the comparison was not a controlled trial and that most timing entries were retrospective estimates. That evidence is useful but early: the next milestone is showing repeatable adoption and operational impact as the UK rollout expands.
Sources checked:
Aisel Health company announcement · Aisel research · 24Victoria · Tech.eu Funding Explorer
